Library Subscription: Guest
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections
Critical Reviews™ in Immunology
IF: 1.404 5-Year IF: 3.347 SJR: 0.706 SNIP: 0.55 CiteScore™: 2.19

ISSN Print: 1040-8401
ISSN Online: 2162-6472

Volumes:
Volume 40, 2020 Volume 39, 2019 Volume 38, 2018 Volume 37, 2017 Volume 36, 2016 Volume 35, 2015 Volume 34, 2014 Volume 33, 2013 Volume 32, 2012 Volume 31, 2011 Volume 30, 2010 Volume 29, 2009 Volume 28, 2008 Volume 27, 2007 Volume 26, 2006 Volume 25, 2005 Volume 24, 2004 Volume 23, 2003 Volume 22, 2002 Volume 21, 2001 Volume 20, 2000 Volume 19, 1999 Volume 18, 1998 Volume 17, 1997 Volume 16, 1996 Volume 15, 1995 Volume 14, 1994

Critical Reviews™ in Immunology

DOI: 10.1615/CritRevImmunol.2014009999
pages 215-225

Biological Function of HLA-DO (H2-O)

Xinjian Chen
ARUP Laboratories, Department of Pathology, University of Utah, Salt Lake City, Utah 84112
Peter E. Jensen
ARUP Laboratories, Department of Pathology, University of Utah, Salt Lake City, Utah 84112

ABSTRACT

HLA-DO (H2-O) is a highly conserved nonpolymorphic major histocompatibility complex class II (MHCII) like molecule expressed in B lymphocytes, dendritic cells, and thymic epithelial cells. The biological function of DO has been elusive. Recent studies using site-directed mutagenesis, crystallography, and enzyme kinetics demonstrate that DO functions strictly as an inhibitor rather than modifier of DM function. DO stably binds to DM at the catalytic site to block DM interaction with MHCII. While the new data establish the molecular mechanism of DO function, the reason that professional antigen-presenting cells (APCs) express DO to generate DO-DM complexes that are functionally inactive remains unclear. Despite the finding that DO inhibits DM, antigen presentation by H2-O-/- APCs is inefficient compared to wild-type (WT) APCs, and H2-O-/- mice are partially immunodeficient and spontaneously develop auto-antibodies to nuclear antigens. The results of functional studies raise the question of how an inhibitor of DM enhances antigen presentation and promotes immunity. In this review, we analyze the related findings from previous and recent studies. The integration of the all of the data allows us to propose a model explaining how DO enhances antigen presentation by inhibiting DM function.


Articles with similar content:

Review: Oncogenic Insertional Mutagenesis as a Consequence of Retroviral Gene Therapy for X-Linked Severe Combined Immunodeficiency Disease
Critical Reviews™ in Eukaryotic Gene Expression, Vol.29, 2019, issue 6
Maria Zafar, Muhammad Imran Qadir, Bilal Ahmed
Linkage of Immune Self-Tolerance with the Positive Selection of T Cells
Critical Reviews™ in Immunology, Vol.19, 1999, issue 3
Robert L. Rubin, Anke Kretz-Rommel
The Impact of Extracellular Acidosis on Dendritic Cell Function
Critical Reviews™ in Immunology, Vol.24, 2004, issue 5
Romina Gamberale, Juan Sabatte, Jorge Raul Geffner, Mirta Giordano, Monica Elba Vermeulen, Ana Ceballos, Diego Martinez, Analia Silvina Trevani
The Yin-Yang of KIR3DL1/S1: Molecular Mechanisms and Cellular Function
Critical Reviews™ in Immunology, Vol.33, 2013, issue 3
Geraldine M. O'Connor, Daniel W. McVicar
Inflammation in Ischemic Brain Injury: Timing Is Important
Critical Reviews™ in Neurobiology, Vol.18, 2006, issue 1-2
Jasna Kriz